The Goldman Sachs Group, Inc. 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:45 pm Sale | 2022-12-30 | 13G | CERO THERAPEUTICS HLDGS INC CERO | GOLDMAN SACHS GROUP INC GS | 0 0.000% | -125 (Position Closed) | Filing |